fluoxetine has been researched along with Bronchopulmonary Dysplasia in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine treatment generated a further increase in muscularisation and did not significantly modify the hyperoxia-induced reductions in alveolar density and increases in the endocrine cells." | 5.38 | Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. ( Baraldi, M; Chiandetti, L; De Caro, R; Fornaro, E; Grisafi, D; Macchi, V; Masola, V; Onisto, M; Porzionato, A; Salmaso, R; Tassone, E; Zaramella, P, 2012) |
| "Fluoxetine treatment generated a further increase in muscularisation and did not significantly modify the hyperoxia-induced reductions in alveolar density and increases in the endocrine cells." | 1.38 | Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats. ( Baraldi, M; Chiandetti, L; De Caro, R; Fornaro, E; Grisafi, D; Macchi, V; Masola, V; Onisto, M; Porzionato, A; Salmaso, R; Tassone, E; Zaramella, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Porzionato, A | 1 |
| Zaramella, P | 1 |
| Macchi, V | 1 |
| Grisafi, D | 1 |
| Salmaso, R | 1 |
| Baraldi, M | 1 |
| Fornaro, E | 1 |
| Tassone, E | 1 |
| Masola, V | 1 |
| Onisto, M | 1 |
| Chiandetti, L | 1 |
| De Caro, R | 1 |
1 other study available for fluoxetine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Base Sequence; Bronchopulmonary | 2012 |